Rarity PBC is a public benefit corporation dedicated to making life-saving gene therapies accessible to those affected by rare genetic diseases. We believe that every patient, regardless of rarity, deserves access to proven, transformative treatments. By focusing on overlooked but clinically validated therapies, we aim to bridge the gap between groundbreaking research and real-world impact, giving hope to patients and families who have long been underserved.
Our lead program centers on ADA-SCID lentiviral vector gene therapy, a pioneering treatment that offers a cure for patients with this severe immunodeficiency disorder. Rarity remains committed to expanding its portfolio to include additional gene therapies for other ultra-rare genetic conditions, staying true to our mission of delivering hope and new possibilities to those who need it most.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Los Angeles, California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://raritypbc.com
- Keywords
- Fertilead Inc..
- HQ
- Los Angeles, California
Rarity Pbc Questions
Rarity Pbc's website is http://raritypbc.com
Rarity Pbc's LinkedIn profile is https://www.linkedin.com/company/raritypbc
Rarity Pbc has
5 employees.
View email and phone details for 5
employees at Rarity Pbc.
Rarity Pbc's industry is
Biotechnology Research
Rarity Pbc's top competitors are
Vetta Consulting,
Maxcyte, Inc.,
Cellvoyant,
Aldevron,
Rarity Bioscience,
Cytokinetics,
A2 Biotherapeutics, Inc.,
Symbrosia,
Resilience,
Fertilead Inc..
Rarity Pbc's categories are Biotechnology Research
Rarity Pbc's founding year is 2023
